Endocrinopathy in POEMS syndrome: The mayo clinic experience

Mayo Clinic Proceedings

Volumn 82, Issue 7, 2007, Pages 836-842

  Gandhi, Gunjan Y ^a   Basu, Rita ^a   Dispenzieri, Angela ^a   Basu, Ananda ^a   Montori, Victor M ^a   Brennan, Michael D ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOTROPIN; CYTOKINE; GLUCOSE; HYDROCORTISONE; PROLACTIN; TESTOSTERONE; VASCULOTROPIN;

ADRENAL GLAND; ADRENAL INSUFFICIENCY; ADULT; ARTICLE; CORTICOTROPIN BLOOD LEVEL; DATA EXTRACTION; DIABETES MELLITUS; DRUG MEGADOSE; ENDOCRINE DISEASE; ENDOCRINE SYSTEM; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; GONAD; GYNECOMASTIA; HUMAN; HYPOCALCEMIA; HYPOGONADISM; HYPOTHYROIDISM; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; PARAPROTEINEMIA; PREVALENCE; PROLACTIN BLOOD LEVEL; PROVOCATION TEST; TESTOSTERONE BLOOD LEVEL; THYROID GLAND;

EID: 34347340413     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/82.7.836     Document Type: Article

References (28)

1. Bardwick PA, Zvaifler NJ, Gill GN, Newman D, Greenway GD, Resnick DL. Plasma cell dyscrasia with polyneuropathy, organomegaly, endocrinopathy, M protein, and skin changes: the POEMS syndrome: report on two cases and a review of the literature. Medicine (Baltimore). 1980;59:311-322.
2. Dispenzieri A, Kyle RA, Lacy MQ, et al. POEMS syndrome: definitions and long-term outcome. Blood. 2003 Apr 1;101:2496-2506. Epub 2002 Nov 27.
3. Nakanishi T, Sobue I, Toyokura Y, et al. The Crow-Fukase syndrome: a study of 102 cases in Japan. Neurology. 1984;34:712-720.
4. Driedger H, Pruzanski W. Plasma cell neoplasia with peripheral polyneuropathy: a study of five cases and a review of the literature. Medicine (Baltimore). 1980;59:301-310.
5. Gherardi RK, Belec L, Soubrier M, et al. Overproduction of proinflammatory cytokines unbalanced by their antagonists in POEMS syndrome. Blood. 1996;87:1458-1465.
6. Hashiguchi T, Arimura K, Matsumuro K, et al. Highly concentrated vascular endothelial growth factor in platelets in Crow-Fukase syndrome. Muscle Nerve. 2000;23:1051-1056.
7. Hitoshi S, Suzuki K, Sakuta M. Elevated serum interleukin-6 in POEMS syndrome reflects the activity of the disease. Intern Med. 1994;33:583-587.
8. Watanabe O, Maruyama I, Arimura K, et al. Overproduction of vascular endothelial growth factor/vascular permeability factor is causative in Crow-Fukase (POEMS) syndrome. Muscle Nerve. 1998;21:1390-1397.
9. Soubrier M, Dubost JJ, Serre AF, et al. Growth factors in POEMS syndrome: evidence for a marked increase in circulating vascular endothelial growth factor. Arthritis Rheum. 1997;40:786-787.
10. Dyck PJ, Engelstad J, Dispenzieri A. Vascular endothelial growth factor and POEMS. Neurology. 2006;66:10-12.
11. Goth MI, Hubina E, Raptis S, Nagy GM, Toth BE. Physiological and pathological angiogenesis in the endocrine system. Microsc Res Tech. 2003;60:98-106.
12. Soubrier MJ, Dubost JJ, Sauvezie BJ, French Study Group on POEMS Syndrome. POEMS syndrome: a study of 25 cases and a review of the literature. Am J Med. 1994;97:543-553.
13. Cabezas-Agricola JM, Lado-Abeal JJ, Otero-Anton E, Sanchez-Leira J, Cabezas-Cerrato J. Hypoparathyroidism in POEMS syndrome. Lancet. 1996;347:701-702.
14. Mauvais-Jarvis F, Bertherat J, Ravaud H, Thomopoulos P, Luton JP. POEMS syndrome with primary adrenocortical insufficiency [in French]. Presse Med. 1998;27:15-17.
15. Gherardi R, Baudrimont M, Kujas M, et al. Pathological findings in three non-Japanese patients with the POEMS syndrome. Virchows Arch A Pathol Anat Histopathol. 1988;413:357-365.
16. Dispenzieri A, Moreno-Aspitia A, Suarez GA, et al. Peripheral blood stem cell transplantation in 16 patients with POEMS syndrome, and a review of the literature. Blood. 2004 Nov 15;104:3400-3407. Epub 2004 Jul 27.
17. Bergouignan FX, Massonnat R, Vital C, et al. Uncompacted lamellae in three patients with POEMS syndrome. Eur Neurol. 1987;27:173-181.
18. Belec L, Authier FJ, Mohamed AS, Soubrier M, Gherardi RK. Antibodies to human herpesvirus 8 in POEMS (polyneuropathy, organomegaly, endocrinopathy, M protein, skin changes) syndrome with multicentric Castleman's disease. Clin Infect Dis. 1999;28:678-679.
19. Gherardi RK, Belec L, Fromont G, et al. Elevated levels of interleukin-1β (IL-1β) and IL-6 in serum and increased production of IL-1β mRNA in lymph nodes of patients with polyneuropathy, organomegaly, endocrinopathy, M protein, and skin changes (POEMS) syndrome. Blood. 1994; 83:2587-2593.
20. Hollowell JG, Staehling NW, Flanders WD, et al. Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab. 2002;87:489-499.
21. Harman SM, Metter EJ, Tobin JD, Pearson J, Blackman MR. Longitudinal effects of aging on serum total and free testosterone levels in healthy men. J Clin Endocrinol Metab. 2001;86:724-731.
22. Cowie CC, Rust KF, Byrd-Holt DD, et al. Prevalence of diabetes and impaired fasting glucose in adults in the U.S. population: National Health and Nutrition Examination Survey 1999-2002. Diabetes Care. 2006;29:1263-1268.
23. Matsumine H. Accelerated conversion of androgen to estrogen in plasma-cell dyscrasia associated with polyneuropathy, anasarca, and skin pigmentation. N Engl J Med. 1985;313:1025-1026.
24. Silberstein LE, Duggan D, Berkman EM. Therapeutic trial of plasma exchange in osteosclerotic myeloma associated with the POEMS syndrome. J Clin Apher. 1985;2:253-257.
25. Shichiri M, Iwashina M, Imai T, Marumo F, Hirata Y. Abnormal FSH hypersecretion as an endocrinological manifestation of POEMS syndrome. Endocr J. 1998;45:131-134.
26. Rosenfeld CR, Tomford JW, Tubbs RR, Reddy SS. POEMS syndrome associated with Castleman's disease. Endocr Pract. 1999;5:29-32.
27. Miralles GD, O'Fallon JR, Talley NJ. Plasma-cell dyscrasia with polyneuropathy: the spectrum of POEMS syndrome. N Engl J Med. 1992;327:1919-1923.
28. Reulecke M, Dumas M, Meier C. Specific antibody activity against neuroendocrine tissue in a case of POEMS syndrome with IgG gammopathy. Neurology. 1988;38:614-616.